GlobeNewswire
BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025
📈
AI Sentiment
Highly Positive
8/10
- Home
- BCTX
as of 12-12-2025 1:50pm EST
$9.90
$0.41
-3.98%
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.
Chart Type:
Time Range:
| Founded: | 2014 | Country: | Canada |
| Employees: | N/A | City: | WEST VANCOUVER |
| Market Cap: | 18.5M | IPO Year: | N/A |
| Target Price: | $40.00 | AVG Volume (30 days): | 55.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -33.79 | EPS Growth: | N/A |
| 52 Week Low/High: | $6.00 - $106.50 | Next Earning Date: | 12-11-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | 380.95% |
AI-Powered BCTX Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 2 days ago
AI Recommendation
hold
Model Accuracy: 72.19%
72.19%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest BriaCell Therapeutics Corp. News
BCTX Breaking Stock News: Dive into BCTX Ticker-Specific Updates for Smart Investing
GlobeNewswire
BriaCell’s Phase 3 Patient Enrollment on Track for 1H2026 Topline Data Readout
📈
AI Sentiment
Highly Positive
8/10
Compare BCTX vs Leading Stocks
See how BCTX stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "BCTX BriaCell Therapeutics Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.